10-K: Paysign Reports Strong Revenue Growth in 2024, Driven by Pharma and Plasma Segments

Paysign's 2024 10-K filing reveals a 23.5% increase in total revenue, fueled by significant growth in the pharma and plasma industries, alongside strategic investments in technology and compliance.

Summary

• Paysign, Inc., a Nevada-based provider of prepaid card products and processing services, reported a 23.5% increase in total revenues for the year ended December 31, 2024, reaching $58.38 million compared to $47.27 million in 2023.
• The revenue growth was primarily driven by a $1.93 million increase in plasma industry revenue and an $8.60 million increase in pharma industry revenue.
• The company manages approximately 600 card programs with approximately 7.3 million participating cardholders as of December 31, 2024.
• Paysign's gross profit increased by 33.4% to $32.20 million, with a gross margin of 55.1% in 2024 compared to 51.1% in 2023.
• Operating expenses increased by 28.3% to $31.18 million, primarily due to increased compensation, benefits, and technology investments.
• Net income for 2024 was $3.82 million, a decrease from $6.46 million in 2023, primarily due to changes in deferred tax asset valuation.
• The company repurchased 136,700 shares of its common stock for $495,045 during 2024.
• Paysign plans to continue investing in technology improvements, sales and marketing, cybersecurity, fraud prevention, customer service, and regulatory compliance in 2025.
• The company believes its available cash and projected revenues and cash flows will be sufficient to sustain operations for the next 24 months.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with strong revenue growth and strategic investments, but also acknowledges challenges such as increased operating expenses and regulatory risks, resulting in a moderately positive sentiment.

Positives

• Significant revenue growth driven by the pharma and plasma industries.
• Improved gross profit margin indicates increased efficiency and profitability.
• Strategic investments in technology and compliance enhance long-term growth potential.
• Effective management of a large number of card programs and cardholders.
• Increase in EBITDA and adjusted EBITDA demonstrates improved operational performance.
• The company believes its available cash and projected revenues and cash flows will be sufficient to sustain operations for the next 24 months.

Negatives

• Net income decreased due to changes in deferred tax asset valuation.
• Increased operating expenses may impact future profitability if not managed effectively.
• The company has a concentration of accounts receivable risk with two pharma customers representing a significant portion of the balance.
• The company had approximately $686,177 in excess of federally insured bank account limits as of December 31, 2024.

Risks

• The company operates in a highly regulated environment, and failure to comply with applicable laws and regulations could have an adverse effect on its business.
• A data security breach could expose the company to liability and protracted and costly litigation.
• The company may have deficiencies or weaknesses in its internal control over financial reporting.
• The industry in which the company competes is highly competitive, which could adversely affect its operating results and financial condition.
• The company relies on relationships with card issuing banks to conduct its business, and its results of operations and financial position could be materially and adversely affected if it fails to maintain these relationships.
• Changes in credit card association or other network rules or standards set by Visa and MasterCard could adversely affect the company's business, financial position and results of operations.
• The company may not be able to successfully manage its intellectual property or may be subject to infringement claims.
• The market for electronic commerce services is evolving and may not continue to develop or grow rapidly enough for the company to maintain profitability.
• Global and regional economic conditions could harm the company's business.
• The company depends on key personnel and could be harmed by the loss of their services because of the limited number of qualified people in its industry.

Future Outlook

Paysign plans to continue investing in technology improvements, sales and marketing, cybersecurity, fraud prevention, customer service, and regulatory compliance in 2025, and believes its available cash and projected revenues and cash flows will be sufficient to sustain operations for the next 24 months.

Industry Context

The prepaid card market continues to experience significant growth due to consumers, corporations and governments embracing improved technology, greater convenience, more product choices and greater flexibility.

Comparison to Industry Standards

• The document mentions Javelin Advisory Services projecting 8% annual growth in the open-loop prepaid market from 2024 through 2027, with total open-loop loads projected to reach $836 billion by 2027.
• The document mentions that according to the 2023 Federal Deposit Insurance Corporation (FDIC) National Survey of Unbanked and Underbanked Households, 5.9 percent of all households were using general purpose reloadable prepaid cards in 2023.
• The document mentions that use of prepaid cards was much higher among unbanked households (21.6 percent) than among banked households (5.2 percent).

Legal Proceedings

• The company was named as a defendant in three securities class action complaints filed in the United States District Court for the District of Nevada.
• The Company has also been named as a nominal defendant in four stockholder derivative actions currently pending in the United States District Court for the District of Nevada.

Stakeholder Impact

• Shareholders: The company's financial performance and strategic initiatives impact shareholder value.
• Employees: The company's investments in compensation and benefits affect employee morale and retention.
• Customers: The company's payment solutions and customer service impact customer satisfaction and loyalty.
• Suppliers: The company's relationships with third-party vendors affect the reliability and cost of its services.
• Creditors: The company's financial stability and cash flow impact its ability to meet its obligations.

Next Steps

• Continue investing in technology improvements, sales and marketing, cybersecurity, fraud prevention, customer service, and regulatory compliance.
• Monitor and manage operating expenses to ensure profitability.
• Continue to monitor the health and soundness of bank relationships through publicly available information.

Key Dates

Keywords

prepaid cards, payment processing, pharma, plasma, revenue growth, financial results, card programs, Paysign, EBITDA, 10-K